FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898850782> ?p ?o ?g. }

• W2898850782 endingPage "286" @default.
• W2898850782 startingPage "275" @default.
• W2898850782 abstract "Purpose: Retinopathy of prematurity (ROP) is a condition of abnormal retinal vascularization with reduced levels of vascular endothelial growth factor (VEGF) causing vaso-obliteration (Phase I), followed by abnormal neovascularization from increased VEGF (Phase II). We hypothesized that intravitreal pro-angiogenic VEGF-A in microparticle form would promote earlier retinal revascularization in an oxygen-induced ischemic retinopathy (OIR) mouse model.Materials and Methods: Wildtype mice (39) were exposed to 77% oxygen from postnatal day 7 (P7) to P12. VEGF-A165-loaded poly(lactic-co-glycolic acid) (PLGA) (n = 15) or empty PLGA (n = 14) microparticles were fabricated using a water-in-oil-in-water double emulsion method, and injected intravitreally at P13 into mice right eyes (RE). Left eyes (LE) were untreated. At P20, after retinal fluorescein angiography, vascular parameters were quantified. Retinal VEGF levels at P13 and flatmounts at P20 were performed separately.Results: VEGF-A165-loaded microparticles had a mean diameter of 4.2 μm. with a loading level of 8.6 weight.%. Retinal avascular area was reduced in VEGF-treated RE (39.5 ± 9.0%) compared to untreated LE (52.6 ± 6.1%, p < 0.0001) or empty microparticle-treated RE (p < 0.001) and untreated LEs (p = 0.001). Retinal arteries in VEGF-treated RE were less tortuous than untreated LE (1.08 ± 0.05 vs. 1.18 ± 0.08, p < 0.001) or empty-microparticles-treated RE (p = 0.02). Retinal arterial tortuosity was similar in the LE of VEGF and empty microparticle-treated mice (P > 0.05). Retinal vein width was similar in VEGF-treated and empty microparticle-treated RE (P > 0.9), which were each less dilated than their contralateral LE (p < 0.01). VEGF levels were higher in P13 OIR mice than RA mice (p < 0.0001). Retinal flatmounts showed vaso-obliteration and neovascularization.Conclusions: Endogenous retinal VEGF is suppressed in OIR mice. Exogenous intravitreal VEGF-A165-loaded microparticles in OIR mice reduced retinal vaso-obliteration and accelerated recovery from vein dilation and arterial tortuosity. This may be beneficial in preventing Phase II ROP without systemic effects." @default.
• W2898850782 created "2018-11-09" @default.
• W2898850782 creator A5001405352 @default.
• W2898850782 creator A5014879534 @default.
• W2898850782 creator A5017204113 @default.
• W2898850782 creator A5022938028 @default.
• W2898850782 creator A5040422732 @default.
• W2898850782 creator A5055164347 @default.
• W2898850782 creator A5061183894 @default.
• W2898850782 date "2018-11-09" @default.
• W2898850782 modified "2023-10-18" @default.
• W2898850782 title "Intravitreal Delivery of VEGF-A₁₆₅-loaded PLGA Microparticles Reduces Retinal Vaso-Obliteration in an<i>In Vivo</i>Mouse Model of Retinopathy of Prematurity" @default.
• W2898850782 cites W1524688066 @default.
• W2898850782 cites W1538850399 @default.
• W2898850782 cites W1548659316 @default.
• W2898850782 cites W1562028693 @default.
• W2898850782 cites W1583921082 @default.
• W2898850782 cites W1757875555 @default.
• W2898850782 cites W1966882402 @default.
• W2898850782 cites W1967004211 @default.
• W2898850782 cites W1969486522 @default.
• W2898850782 cites W1969989481 @default.
• W2898850782 cites W1973197740 @default.
• W2898850782 cites W1973677429 @default.
• W2898850782 cites W1976644140 @default.
• W2898850782 cites W1984440342 @default.
• W2898850782 cites W1992155535 @default.
• W2898850782 cites W1994935582 @default.
• W2898850782 cites W1998852117 @default.
• W2898850782 cites W1998874347 @default.
• W2898850782 cites W2003858793 @default.
• W2898850782 cites W2006861443 @default.
• W2898850782 cites W2007495580 @default.
• W2898850782 cites W2007763447 @default.
• W2898850782 cites W2014546288 @default.
• W2898850782 cites W2017546292 @default.
• W2898850782 cites W2027173123 @default.
• W2898850782 cites W2027939537 @default.
• W2898850782 cites W2033254113 @default.
• W2898850782 cites W2039200973 @default.
• W2898850782 cites W2043389111 @default.
• W2898850782 cites W2047661114 @default.
• W2898850782 cites W2056192765 @default.
• W2898850782 cites W2060993142 @default.
• W2898850782 cites W2061537454 @default.
• W2898850782 cites W2072175608 @default.
• W2898850782 cites W2078725062 @default.
• W2898850782 cites W2081365179 @default.
• W2898850782 cites W2082054044 @default.
• W2898850782 cites W2096257823 @default.
• W2898850782 cites W2098582960 @default.
• W2898850782 cites W2100141665 @default.
• W2898850782 cites W2113170046 @default.
• W2898850782 cites W2121496050 @default.
• W2898850782 cites W2131393213 @default.
• W2898850782 cites W2132122521 @default.
• W2898850782 cites W2135639275 @default.
• W2898850782 cites W2139194938 @default.
• W2898850782 cites W2141046053 @default.
• W2898850782 cites W2152490588 @default.
• W2898850782 cites W2164971856 @default.
• W2898850782 cites W2167599976 @default.
• W2898850782 cites W2181637367 @default.
• W2898850782 cites W2220860297 @default.
• W2898850782 cites W2327041238 @default.
• W2898850782 cites W2513578631 @default.
• W2898850782 cites W2613436323 @default.
• W2898850782 cites W2626137137 @default.
• W2898850782 cites W2750685187 @default.
• W2898850782 doi "https://doi.org/10.1080/02713683.2018.1542736" @default.
• W2898850782 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6661072" @default.
• W2898850782 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30383455" @default.
• W2898850782 hasPublicationYear "2018" @default.
• W2898850782 type Work @default.
• W2898850782 sameAs 2898850782 @default.
• W2898850782 citedByCount "15" @default.
• W2898850782 countsByYear W28988507822020 @default.
• W2898850782 countsByYear W28988507822021 @default.
• W2898850782 countsByYear W28988507822022 @default.
• W2898850782 countsByYear W28988507822023 @default.
• W2898850782 crossrefType "journal-article" @default.
• W2898850782 hasAuthorship W2898850782A5001405352 @default.
• W2898850782 hasAuthorship W2898850782A5014879534 @default.
• W2898850782 hasAuthorship W2898850782A5017204113 @default.
• W2898850782 hasAuthorship W2898850782A5022938028 @default.
• W2898850782 hasAuthorship W2898850782A5040422732 @default.
• W2898850782 hasAuthorship W2898850782A5055164347 @default.
• W2898850782 hasAuthorship W2898850782A5061183894 @default.
• W2898850782 hasBestOaLocation W28988507821 @default.
• W2898850782 hasConcept C118487528 @default.
• W2898850782 hasConcept C126322002 @default.
• W2898850782 hasConcept C134018914 @default.
• W2898850782 hasConcept C150903083 @default.
• W2898850782 hasConcept C167734588 @default.
• W2898850782 hasConcept C169760540 @default.
• W2898850782 hasConcept C185592680 @default.
• W2898850782 hasConcept C202751555 @default.
• W2898850782 hasConcept C207001950 @default.

• next